- Latest available (Revised)
- Original (As adopted by EU)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.![]()
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market(1), and in particular the second subparagraph of Article 16(2) thereof,
Whereas:
(1) Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market(2) establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
(2) For a number of substance/product type combinations included in that list, either all participants have discontinued their participation in the review programme, or no complete dossier was received within the time period specified in Articles 9 and 12(3) of Regulation (EC) No 1451/2007 by the Member State designated as rapporteur for the evaluation.
(3) Consequently, and pursuant to Articles 11(2), 12(1) and 13(5) of Regulation (EC) No 1451/2007, the Commission informed the Member States accordingly. That information was also made public by electronic means.
(4) Within the period of three months from those publications, a number of companies indicated an interest in taking over the role of participant for certain of the substances and product types concerned. However, those companies subsequently failed to submit a complete dossier.
(5) Pursuant to Articles 12(4) and 12(5) of Regulation (EC) No 1451/2007, the substances and product types concerned should therefore not be included in Annexes I, IA or IB to Directive 98/8/EC.
(6) In the interest of legal certainty, it is appropriate to specify the date after which biocidal products of the product types listed in the Annex to this Decision containing the active substances listed in that Annex should no longer be placed on the market.
(7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS DECISION:
The substances indicated in the Annex to this Decision shall not be included for the product types concerned in Annexes I, IA or IB to Directive 98/8/EC.
For the purposes of Article 4(2) of Regulation (EC) No 1451/2007, biocidal products of the product types listed in the Annex to this Decision which contain the active substances listed in that Annex shall no longer be placed on the market with effect from 1 February 2013.
This Decision is addressed to the Member States.
Done at Brussels, 9 February 2012.
For the Commission
Janez Potočnik
Member of the Commission
| Name | EC number | CAS number | Product type | Rapporteur Member State |
|---|---|---|---|---|
| Cyclohexylhydroxydiazene 1-oxide, potassium salt | 66603-10-9 | 6 | AT | |
| Cyclohexylhydroxydiazene 1-oxide, potassium salt | 66603-10-9 | 7 | AT | |
| Cyclohexylhydroxydiazene 1-oxide, potassium salt | 66603-10-9 | 9 | AT | |
| Cyclohexylhydroxydiazene 1-oxide, potassium salt | 66603-10-9 | 10 | AT | |
| Cyclohexylhydroxydiazene 1-oxide, potassium salt | 66603-10-9 | 12 | AT | |
| Cyclohexylhydroxydiazene 1-oxide, potassium salt | 66603-10-9 | 13 | AT | |
| Diphenoxarsin-10-yl oxide | 200-377-3 | 58-36-6 | 9 | FR |
| Glyoxal | 203-474-9 | 107-22-2 | 12 | FR |
| 1,3-dichloro-5,5-dimethylhydantoin | 204-258-7 | 118-52-5 | 12 | NL |
| Tosylchloramide sodium | 204-854-7 | 127-65-1 | 11 | ES |
| Disodium tetraborate, anhydrous | 215-540-4 | 1330-43-4 | 11 | NL |
| Copper | 231-159-6 | 7440-50-8 | 2 | FR |
| Copper | 231-159-6 | 7440-50-8 | 4 | FR |
| Copper | 231-159-6 | 7440-50-8 | 5 | FR |
| Copper | 231-159-6 | 7440-50-8 | 11 | FR |
| Copper sulphate | 231-847-6 | 7758-98-7 | 1 | FR |
| Copper sulphate | 231-847-6 | 7758-98-7 | 4 | FR |
| Calcium hypochlorite | 231-908-7 | 7778-54-3 | 1 | IT |
| Boric acid | 233-139-2 | 10043-35-3 | 22 | NL |
| Trimagnesium diphosphide | 235-023-7 | 12057-74-8 | 20 | DE |
| Chloralose | 240-016-7 | 15879-93-3 | 15 | PT |
| Chloralose | 240-016-7 | 15879-93-3 | 23 | PT |
| Aluminium phosphide | 244-088-0 | 20859-73-8 | 20 | DE |
| 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione | 401-570-7 | 89415-87-2 | 12 | NL |
| Methyl neodecanamide | 414-460-9 | 105726-67-8 | 19 | ES |
| Tetrachlorodecaoxide complex | 420-970-2 | 92047-76-2 | 5 | DE |
| 3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide | 431-030-6 | 163269-30-5 | 9 | PT |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 2 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 2 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 3 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 3 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 4 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 4 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 7 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 7 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 9 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 9 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 10 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 10 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 11 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 11 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 12 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 12 | FR |
| Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride) | Polymer | 374572-91-5 | 20 | FR |
| Poly(hexamethylendiamine guanidinium chloride) | Polymer | 57028-96-3 | 20 | FR |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: